Liver damage is part of the multiple organ failure (MOF) syndrome which frequently follows successful resuscitation of traumatized/septic surgical patients. We have shown that Kupffer cells (KC) have profound effects on hepatocyte (HC) metabolism in vitro. Most significantly, we showed that a mixture of IFNg and LPS plus KC cytokines (IL-1, TNF) act synergistically in vitro on HC to upregulate a unique inducible enzyme, nitric oxide (N=O) synthase, which converts arginine to N=O plus citrulline. In turn, N=O inhibits HC protein synthesis via a post-translational mechanism, upregulates guanylate cyclase, and impairs mitochondrial function. HC N=O synthase is also induced in vivo in inflammatory states and enzyme inhibition under these conditions produces hepatic necrosis. Thus, the importance of N=O synthase to hepatic dysfunction in sepsis cannot be overlooked. The goal of this proposal is to explore the factors in vitro and in vivo which regulate HC N=O synthase activity. We hypothesize that one or more of the cytokines are inductive cytokines which control N=O synthase gene expression, while others are adjuvant cytokines which control pre- and post-transcriptional events.
In AIM I, therefore, we will determine: a) the substrate and cofactor requirements of the enzyme; b) which cytokine(s) acts to express the HC gene for the enzyme; and c) which cytokine(s) regulate cofactor availability, alter cytokine receptor expression, and control second messenger systems. The possibility that endogenous competitive inhibitors, glucocorticoids, eicosanoids, and other cytokines downregulate N=O synthase activity will also be explored in vitro and in experimental models of sepsis in vivo. The experiments are simple. Purified HC will be exposed in vitro to putative regulators of N=O synthase activity. A comparison of enzyme activity in cells, cytosols, and purified protein with mRNA expression will help distinguish between those factors which regulate gene expression and various pre- or post-transcriptional events. Selected in vivo models to test the physiologic significance of the in vitro studies will be set up. In order to fully understand the cytokine regulation of N=O synthase mRNA expression, we need to purify the enzyme and clone the cDNA for HC N=O synthase (AIM II). Thus, by combining molecular techniques with the conventional techniques of cell biology and experimental in vivo modeling, we can gain a more complete understanding of both the mechanisms and the physiologic importance of N=O synthase regulation.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM037753-07
Application #
3293416
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1987-12-01
Project End
1995-11-30
Budget Start
1992-12-01
Budget End
1993-11-30
Support Year
7
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Loughran, P A; Stolz, D B; Vodovotz, Y et al. (2005) Monomeric inducible nitric oxide synthase localizes to peroxisomes in hepatocytes. Proc Natl Acad Sci U S A 102:13837-42
Mahidhara, Raja S; Hoffman, Rosemary A; Huang, Sulan et al. (2003) Nitric oxide-mediated inhibition of caspase-dependent T lymphocyte proliferation. J Leukoc Biol 74:403-11
Stolz, Donna Beer; Zamora, Ruben; Vodovotz, Yoram et al. (2002) Peroxisomal localization of inducible nitric oxide synthase in hepatocytes. Hepatology 36:81-93
Zamora, R; Vodovotz, Y; Alarcon, L et al. (2001) Nitric oxide from the inducible nitric oxide synthase (iNOS) increases the expression of cytochrome P450 2E1 in iNOS-null hepatocytes in the absence of inflammatory stimuli. Arch Biochem Biophys 390:287-94
Kim, Y M; Chung, H T; Simmons, R L et al. (2000) Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition. J Biol Chem 275:10954-61
Villavicencio, R T; Liu, S; Kibbe, M R et al. (2000) Induced nitric oxide inhibits IL-6-induced stat3 activation and type II acute phase mRNA expression. Shock 13:441-5
Li, J; Billiar, T R (2000) The role of nitric oxide in apoptosis. Semin Perinatol 24:46-50
Li, J; Billiar, T R (1999) The anti-apoptotic actions of nitric oxide in hepatocytes. Cell Death Differ 6:952-5
Taylor, B S; Shao, L; Gambotto, A et al. (1999) Inhibition of cytokine-induced nitric oxide synthase expression by gene transfer of adenoviral I kappa B alpha. Surgery 126:142-7
Li, J; Billiar, T R (1999) Nitric Oxide. IV. Determinants of nitric oxide protection and toxicity in liver. Am J Physiol 276:G1069-73

Showing the most recent 10 out of 116 publications